Indomethacin suppositories on pregnancy outcomes in IVF
Phase 2
- Conditions
- Female infertility.Female infertility associated with anovulationN97.0
- Registration Number
- IRCT20160523028008N29
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Age between 18 and 40 years,
History of at least two unsuccessful embryo transfers,
Having at least two A-grade embryos, unknown causes of IVF failure
Unknown causes of IVF failure
Body mass index (BMI) less than 30 kg/m²
Exclusion Criteria
History of any sensitivity to NSAIDs,
Uncontrolled chronic diseases,
Prohibition of NSAID use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: 14 day after embryo transfer. Method of measurement: The B- hCG level is greater than 20 IU/L after 14 days of embryo transfer,.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer” in English 1. Method of measurement: The sight of a pregnancy sac accompanied by the fetal heartbeat 4 weeks after embryo transfer.
- Secondary Outcome Measures
Name Time Method